Breast Cancer and HIV: State of the Art and Practical Implications

Breast cancer is most common in women, and its incidence in HIV population, after the introduction of antiretroviral therapy, has increased to a level approaching that of the general population. This review will be focused on breast cancer in HIV-positive patients with particular reference to epidem...

Full description

Saved in:
Bibliographic Details
Published in:SN comprehensive clinical medicine Vol. 3; no. 8; pp. 1727 - 1739
Main Authors: Lasagna, Angioletta, Zuccaro, Valentina, Sacchi, Paolo, Pagnucco, Layla, Ferraris, Elisa, Armani, Giovanna, Rizzo, Gianpiero, Tancredi, Richard J., Pedrazzoli, Paolo
Format: Journal Article
Language:English
Published: Cham Springer International Publishing 08-05-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Breast cancer is most common in women, and its incidence in HIV population, after the introduction of antiretroviral therapy, has increased to a level approaching that of the general population. This review will be focused on breast cancer in HIV-positive patients with particular reference to epidemiology, screening strategies, clinico-pathological features, and treatment, including the interaction between chemotherapy and HAART. Recent cohort studies on HIV-positive women have clearly shown a shift towards increasing breast cancer incidence, with levels now approaching those in the HIV-negative population. Screening disparities exist yet between HIV-positive and HIV-negative women emphasizing the importance of biennial mammography to detect early breast cancer in women aged 50–74 years, who live with HIV/AIDS. Cancer stage, cancer pathology characteristics, and survival outcome are similar in HIV-positive and HIV-negative patients, although the fear of additional complications and toxicity often leads to HIV-positive patients receiving sub-optimal treatment. The best management of breast cancer in HIV patients consists in a multidisciplinary approach between oncologists and infectious disease specialists to guarantee the patients the correct diagnostic work-up and the most appropriate therapeutic approach aiming to reduce drug-drug interactions and overlapping toxicities of both treatments.
ISSN:2523-8973
2523-8973
DOI:10.1007/s42399-021-00950-z